Junkai Wang

DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer

R. Matsunuma, D. Chan, B. Kim, 2018, Proceedings of the National Academy of Sciences.

Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).

Junkai Wang, M. Ellis, T. Nielsen, 2019, Journal of the National Cancer Institute.

DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells

Junkai Wang, Jiang-wei Ma, Qiong Zhang, 2019, Artificial cells, nanomedicine, and biotechnology.

Poziotinib Inhibits HER2-Mutant–Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer

Junkai Wang, M. Anurag, B. Karanam, 2022, Cancer research.

Kinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics

Matthew V. Holt, D. Chan, B. Kim, 2022, bioRxiv.

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Matthew V. Holt, Alexander B. Saltzman, Junkai Wang, 2023, Cancer research communications.